These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4362007)

  • 1. Comparison of the ribonucleotide with the canavanine reductase system.
    Schultz A; Sasaki M; Natelson S
    Proc Soc Exp Biol Med; 1974 Mar; 145(3):884-8. PubMed ID: 4362007
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the reductive cleavage of canavanine and canavaninosuccinic acid.
    Takahara K; Nakanishi S; Natelson S
    Arch Biochem Biophys; 1971 Jul; 145(1):85-95. PubMed ID: 5001232
    [No Abstract]   [Full Text] [Related]  

  • 3. The sulfhydryl groups of citrate cleavage enzyme.
    Cottam GL; Srere PA
    Arch Biochem Biophys; 1969 Mar; 130(1):304-11. PubMed ID: 4888278
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
    Sato A; Bacon PE; Cory JG
    Adv Enzyme Regul; 1984; 22():231-41. PubMed ID: 6089512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOME PROPERTIES OF URICASE FROM THE HOUSEFLY, MUSCA DOMESTICA.
    NELSON M
    Comp Biochem Physiol; 1964 May; 12():37-46. PubMed ID: 14195394
    [No Abstract]   [Full Text] [Related]  

  • 6. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
    Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
    Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between levels of ferritin and the iron-containing component of ribonucleotide reductase in hydroxyurea-sensitive, -resistant, and -revertant cell lines.
    Hurta RA; Wright JA
    Biochem Cell Biol; 1991 Sep; 69(9):635-42. PubMed ID: 1793565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor growth and disulfide reduction: possible dependence on protein-disulfide reductase.
    Apffel CA; Walker JE; Nathanson IT
    J Natl Cancer Inst; 1973 Aug; 51(2):575-83. PubMed ID: 4148784
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of iron-chelating agents on inhibitors of ribonucleotide reductase.
    Cory JG; Lasater L; Sato A
    Biochem Pharmacol; 1981 May; 30(9):979-84. PubMed ID: 6786297
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymatic ribonucleotide reduction in wheat.
    Müller H; Wahl R; Kuntz I; Follmann H
    Hoppe Seylers Z Physiol Chem; 1973; 354(10-11):1299-303. PubMed ID: 4154887
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of ribonucleotide reductase by caracemide.
    Moore EC; Loo TL
    Cancer Treat Rep; 1984 Oct; 68(10):1293-4. PubMed ID: 6395952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis.
    Chitambar CR; Wereley JP
    Cancer Res; 1995 Oct; 55(19):4361-6. PubMed ID: 7671248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactions of purines-containing butenolides with L-cysteine or N-acetyl-L-cysteine as model biological nucleophiles: a potent mechanism-based inhibitor of ribonucleotide reductase caused apoptosis in breast carcinoma MCF7 cells.
    Hakimelahi GH; Moosavi-Movahedi AA; Sambaiah T; Zhu JL; Ethiraj KS; Pasdar M; Hakimelahi S
    Eur J Med Chem; 2002 Mar; 37(3):207-17. PubMed ID: 11900865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of canavanine and 2,3-dimercapto-1-propanol (British antilewisite) on the proliferation of Novikoff hepatoma cells in the presence of concanavalin A.
    Doyle DG; Bratton GR; Natelson S
    Clin Physiol Biochem; 1983; 1(6):305-17. PubMed ID: 6680093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ribonucleotide reductase in Propionibacterium shermani].
    Iordan EP; Vorob'eva LI; Gaĭtan VI
    Mikrobiologiia; 1975; 44(4):609-14. PubMed ID: 241003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron binding capacity of trimidox (3,4,5-trihydroxybenzamidoxime), a new inhibitor of the enzyme ribonucleotide reductase.
    Szekeres T; Vielnascher E; Novotny L; Vachalkova A; Fritzer M; Findenig G; Göbl R; Elford HL; Goldenberg H
    Eur J Clin Chem Clin Biochem; 1995 Nov; 33(11):785-9. PubMed ID: 8620054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ribonucleotide reductase activity and its possible exploitation in chemotherapy.
    Witt L; Yap T; Blakley RL
    Adv Enzyme Regul; 1978; 17():157-71. PubMed ID: 316642
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of ferrous ion and dithioerythritol on inhibition by hydroxyruea of ribonucleotide reductase.
    Moore EC
    Cancer Res; 1969 Feb; 29(2):291-5. PubMed ID: 4885386
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin.
    McClarty GA; Chan AK; Wright JA
    Cancer Res; 1986 Sep; 46(9):4516-21. PubMed ID: 2425956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis.
    Furukawa T; Naitoh Y; Kohno H; Tokunaga R; Taketani S
    Life Sci; 1992; 50(26):2059-65. PubMed ID: 1608289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.